# CORRESP — Silexion Therapeutics Corp  (SLXN, SLXNW)  (CIK 0002022416)

> <strong>Silexion Therapeutics Corp  (SLXN, SLXNW)  (CIK 0002022416) → SEC staff</strong> · filed 2025-09-09 · ticker SLXN, SLXNW · SIC 2836

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001178913-25-003280
- **Form:** CORRESP
- **Filer:** Silexion Therapeutics Corp  (SLXN, SLXNW)  (CIK 0002022416)
- **CIK:** 0002022416
- **Ticker:** SLXN, SLXNW
- **Filed:** 2025-09-09
- **SIC industry:** 2836
- **HQ:** Ramat Gan, L3

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/2022416/000117891325003280/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2022416&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for Silexion Therapeutics Corp  (SLXN, SLXNW)  (CIK 0002022416)

- CORRESP — 2026-06-16 — /comment-letter/0001178913-26-003203
- UPLOAD — 2026-06-15 — /comment-letter/0000000000-26-005985
- CORRESP — 2025-09-30 — /comment-letter/0001178913-25-003421
- UPLOAD — 2025-09-29 — /comment-letter/0000000000-25-010616
- CORRESP — 2025-09-09 — /comment-letter/0001178913-25-003278

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, Silexion Therapeutics Corp  (SLXN, SLXNW)  (CIK 0002022416) (CIK 0002022416), filed 2025-09-09, accession 0001178913-25-003280. Retrieved via MORVS 2026-11-04 from https://api.morvs.ai/comment-letter/0001178913-25-003280.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*